The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.


Time/Date Code Headline Source Impact
12:00 23-May-2016 SAR Clinical Trials CHK1 Inhibitor CCT245737 to Open RNS -2.81% Down
07:00 17-May-2016 SAR Change of Director RNS +8.65% Up
10:38 05-Apr-2016 SAR CHK1 Approved for Clinical Trials RNS +18.04% Up
11:54 24-Mar-2016 SAR Placing RNS -7.84% Down
07:00 14-Mar-2016 SAR Issue of Options RNS +12.62% Up
12:55 10-Mar-2016 SAR Share price movement RNS +43.07% Up
07:01 24-Feb-2016 SAR Research & Co-Development Collaborations Update RNS +14.44% Up
07:00 24-Feb-2016 SAR Half-Yearly Results for December 2015 RNS +14.44% Up
07:00 01-Feb-2016 SAR CHK1 Clinical Trial Application Submissions RNS +9.72% Up
11:20 15-Dec-2015 SAR Result of AGM RNS +1.06% Up
07:00 15-Dec-2015 SAR CHK1 Clinical Trial Applications RNS +1.06% Up
10:15 13-Nov-2015 SAR Notice of AGM RNS -4.98% Down
07:00 26-Oct-2015 SAR Final Results RNS -8.91% Down
07:00 15-Sep-2015 SAR US and European Patent Grants for Aurora+FLT3 RNS +3.28% Up
07:00 23-Jul-2015 SAR CHK1 Research Update RNS +4.41% Up
07:00 17-Jun-2015 SAR Funding Award from Innovate UK RNS -5.86% Down

Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.

Company Information
Updated Monthly
Company address Unit 2a, Langford Arch, London Road, Pampisford, Cambridge, CB22 3FX, United Kingdom
Company website
Market cap(in millions)* £ 20.65
Listing/Admission to trading 11 Oct 2004
Trading service SEAQ
Market AIM
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
FTSE index FTSE AIM All-Share,FTSE AIM All-Share - Health Care
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Pharmaceuticals
Country of share register GB
Segment AIM
MiFID Status MTF
Exchange market size 200,000
ISIN number GB00B02RFS12

SAREUM share news analysis (SAR)